CSTB and ovarian carcinoma: In our study, the level of cystatin B increased in abdominal exudate in benign tumours (compared to the control serum, p<0.05), as well as in ascetic fluids (p<0.001 vs. serum of the control group) in ovarian cancer of stages II–IV (Fig. 2).